Differentiation of mesothelioma cells is influenced by the expression of proteoglycans

Experimental Cell Research

Volumn 258, Issue 1, 2000, Pages 12-22

  Dobra, Katalin ^a   Andäng, Michael ^b   Syrokou, Alexandra ^c   Karamanos, Nikos K ^c   Hjerpe, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

Cell cell interactions; Cell matrix interactions; Differentiation; Mesothelioma; Proteoglycans; Syndecan

Indexed keywords

BIGLYCAN; DECORIN; ISOPROTEIN; PROTEOGLYCAN; SYNDECAN; SYNTHETASE; VERSICAN;

ARTICLE; CANCER GROWTH; CELL AGGREGATION; CELL DIFFERENTIATION; CELL INTERACTION; CELL SHAPE; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MESOTHELIOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0343628045     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4915     Document Type: Article

References (44)

1. Fusco V., Ardizzoni A., Merlo F., Cinquegrana A., Faravelli B., De Palma M., Chessa L., Nicolo G., Serra M., Capaccioa M. Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patients. Anticancer Res. 13:1993;683-689.
2. Klominek J., Robert K.-H., Hjerpe A., Wickström B., Gahrton G. Serum-dependent growth patterns of two, newly established human mesothelioma cell lines. Cancer Res. 49:1989;6118-6122.
3. Tzanakakis G. N., Karamanos N. K., Klominek J., Hjerpe A. Glycosaminoglycans from two human malignant mesothelioma cell lines: Determination, distribution and effect of platelet-derived growth factor on their synthesis. Biochem. Cell Biol. 73:1995;59-66.
4. Tzanakakis G. N., Karamanos N. K., Klominek J., Hjerpe A. Effects of glycosaminoglycan synthesis in cultured human mesothelioma cells of transforming, epidermal, and fibroblast growth factors and their combinations with platelet-derived growth factor. Exp. Cell Res. 220:1995;130-137.
5. Lories V., Cassiman J.-J., van den Berghe H., David G. Differential expression of cell surface heparan sulfate proteoglycans in human mammary epithelial cells and lung fibroblasts. J. Biol. Chem. 267:1992;1116-1122.
6. David G., Bai X. M., van der Schueren B., Marynen P., Cassiman J.-J., van den Berghe H. Spatial and temporal changes in the expression of fibroglycan (syndecan-2) during mouse embryonic development. Development. 119:1993;841-854.
7. Mali M., Jaakkola P., Arvilommi A. M., Jalkanen M. Sequence of human syndecan indicates a novel gene family of integral membrane proteoglycans. J. Biol. Chem. 265:1990;6884-6889.
8. Woods A., Couchman J. R. Syndecan-4 heparan sulfate proteoglycan is a selectively enriched and widespread focal adhesion component. J. Cell Sci. 313:1992;87-96.
9. Paine-Saunders S., Viviano B. L., Saunders S. GPC6, a novel member of the glypican gene family, encodes a product structurally related to GPC4 and is colocalized with GPC5 on human chromosome 13. Genomics. 57:1999;455-458.
10. Esko J. D. Genetic analysis of proteoglycan structure, function and metabolism. Curr. Opinion Cell. Biol. 3:1991;805-816.
11. Carey D. J. Syndecans: Multifunctional cell-surface co-receptors. Biochem. J. 327:1997;1-16.
12. Sanderson R. D., Turnbull J. E., Gallagher J. T., Lander A. D. Fine structure of heparan sulfate regulates syndecan-1 function and cell behavior. J. Biol. Chem. 269:1994;13100-13106.
13. David G. Integral membrane heparan sulfate proteoglycans. FASEB J. 7:1993;1023-1030.
14. Kato M., Saunders S., Nguyen H., Bernfield M. Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. Mol. Biol. Cell. 6:1995;559-576.
15. Liebersbach B. F., Sanderson R. D. Expression of syndecan-1 inhibits cell invasion into type I collagen. J. Biol. Chem. 269:1994;20013-20019.
16. Mali M., Andtfolk H., Miettinen H. M., Jalkanen M. Suppression of tumor cell growth by syndecan-1 ectodomain. J. Biol. Chem. 269:1994;27795-27798.
17. Inki P., Larjava H., Haapasalmi K., Miettinen H. M., Grenman R., Jalkanen M. Expression of syndecan-1 is induced by differentiation and suppressed by malignant transformation of human keratinocytes. Eur. J. Cell Biol. 63:1994;43-51.
18. Pulkkinen J. O., Penttinen M., Jalkanen M., Klemi P., Grenman R. Syndecan-1: A new prognostic marker in laryngeal cancer. Acta Oto-Laryngol. 117:1997;312-315.
19. Bernfield M., Götte M., Park P. Y., Reizes O., Fitzgerald M. L., Lincecum J., Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68:1999;729-777.
20. Takada J., Shinkai F., Kondo S., Yamamoto S., Tsuboi H., Korenaga R., Ando J. Fluid shear stress increases the expression of thrombomodulin by cultured human endothelial cells. Biochem. Biophys. Res. Commun. 205:1994;1345-1352.
21. Wijdenes J., Vooijs W. C., Clement C., Post J., Morard F., Vita N., Laurent P., Sun R. X., Klen B., Dore J. M. A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. Br. J. Haematol. 94:1996;318-323.
22. David G., van der Schueren B., Marynen P., Cassiman J.-J., van den Berghe H. Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells. J. Cell Biol. 118:1992;961-969.
23. Isogai Z., Shinomura T., Yamakawa N., Takeuchi J., Tsuji T., Heinegård D., Kimata K. 2B1 antigen characteristically expressed on extracellular matrices of human malignant tumors is a large chondroitin sulfate proteoglycan, PG-M/versican. Cancer Res. 56:1996;3902-3908.
24. Sobue M., Nakashima T., Fukatsu T., Nagasaka T., Kato T., Ogura T., Takeuchi J. Production and characterization of monoclonal antibody to dermatan sulfate proteoglycan. J. Histochem. Cytochem. 36:1988;479.
25. Han A. C., Peralta-Soler A., Knudsen K. A., Wheelock M. J., Johnson K. R., Salazar H. Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues. Human Pathol. 28:1997;641-645.
26. Gulyás M., Dobra K., Hjerpe A. Expression of genes coding for proteoglycans and Wilms' tumor susceptibility gene 1 (WT1) by variously differentiated benign human mesothelial cells. Differentiation. 65:1999;89-96.
27. Kumar-Shing S., Jacobs W., Dhaene K., Weyn B., Bogers J., Weyler J., van Marck E. Syndecan-1 expression in malignant mesothelioma: Correlation with cell differentiation, WT1 expression and clinical outcome. J. Pathol. 186:1998;300-305.
28. Bansal R., Kumar M., Murray K., Pfeiffer S. E. Developmental and FGF-2-mediated regulation of syndecans (1-4) and glypican in oligodendrocytes. Mol. Cell Neurosci. 7:1996;276-288.
29. Sanderson R. D., Hinkes M. T., Bernfield M. Syndecan-1, a cell-surface proteoglycan, changes in size and abundance when keratinocytes stratify. J. Invest. Dermatol. 99:1992;390-396.
30. Ridley R. C., Xiao H., Hata H., Woodliff J., Epstein J., Sanderson R. D. Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen. Blood. 81:1993;767-774.
31. Ohiwa N., Fukata S., Fukatsu T., Nagasaka T., Nara Y., Lai S., Nakashima N., Takeuchi J. Immunohistochemical localization of proteoglycans in non-epithelial tumor tissues. Connect. Tissue. 22:1991;11-19.
32. Nara Y., Kato Y., Torii Y., Tsuji Y., Nakagaki S., Goto S., Isobe H., Nakashima N., Takeuchi J. Immunohistochemical localization of extracellular matrix components in human breast tumors with special reference to PG-M/versican. Histochem. J. 29:1997;21-30.
33. Ricciardelli C., Mayne K., Sykes P. J., Raymond W. A., McCaul K., Marshall V. R., Horsfall D. J. Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer. Clin. Cancer Res. 4:1998;963-971.
34. Yamagata M., Kimata K. Repression of malignant cell-substratum adhesion phenotype by inhibiting the production of the anti-adhesive proteoglycan, PG-M/versican. J. Cell Sci. 107:1994;2581-2590.
35. Marynen P., Zhang J., Cassiman J. J., van den Berghe H., David G. Partial primary structure of the 48- and 90-kilodalton core proteins of cell surface-associated heparan sulfate proteoglycans of lung fibroblasts. J. Biol. Chem. 264:1989;7017-7024.
36. David G., Lories V., Decock B., Marynen P., Cassiman J. J., van den Berghe H. Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblasts. J. Cell Biol. 111:1990;3165-3176.
37. Kugelman L. C., Ganguly S., Haggerty J. G., Weissman S. M., Milstone L. M. The core protein of epican, a heparan sulfate proteoglycan on keratinocytes, is an alternative form of CD44. J. Invest. Dermatol. 99:1992;381-385.
38. Jindal S. K., Ishii E., Letarte M., Vera S., Teerds K. J., Dorrington J. H. Regulation of transforming growth factor α gene expression in an ovarian surface epithelial cell line derived from a human carcinoma. Biol. Reprod. 52:1995;1027-1037.
39. Wahab N. A., Harper K., Mason R. M. Expression of extracellular matrix molecules in human mesangial cells in response to prolonged hyperglycaemia. Biochem. J. 316:1996;985-992.
40. Geerkens C., Vetter U., Just W., Fedarko N. S., Fisher L. W., Young M. F., Termine J. D., Robey P. G., Wöhrle D., Vogel W. The X-chromosomal human biglycan gene BGN is subject to X inactivation, but is transcribed like an X-Y homologous gene. Human Genet. 96:1995;44-52.
41. Glumoff V., Savontaus M., Vehanen J., Vuorio E. Analysis of aggrecan and tenascin gene expression in mouse skeletal tissues by Northern and in situ hybridization using species specific cDNA probes. Biochim. Biophys. Acta. 12:1994;613-622.
42. Dours-Zimmermann M. T., Zimmermann D. R. A novel glycosaminoglycan attachment domain identified in two alternative splice variants of human versican. J. Biol. Chem. 269:1994;32992-32998.
43. van Det N. F., van den Born J., Tamsma J. T., Verhagen N. A. M., van den Heuvel L. P. J. W., Berden J. H. M., Bruijn J. A., Daha M. R., van der Woude F. J. Proteoglycan production by human glomerular visceral epithelial cells and mesangial cells in vitro. Biochem. J. 307:1995;759-768.
44. Fort P., Marty L., Piechaczyk M., Sabrouty S. E., Dani C., Jeanteur P., Blanchard J. M. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 13:1985;1431-1441.